A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors

K. Mross, Heike Richly, N. Schleucher, S. Korfee, Mitra Tewes, M. E. Scheulen, S. Seeber, T. Beinert, Michael Schweigert, Uwe Sauer,

Annals of Oncology · 2004 · 25 citations · 26 references

Concepts

References

26